A Multi-Institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer

Aurélie Garant(The University of Texas Southwestern Medical Center), Kenneth W. Merrell(Mayo Clinic), David M. Routman(Mayo Clinic in Arizona), William S. Harmsen(Mayo Clinic), Christopher L. Hallemeier(Mayo Clinic in Arizona), Michael G. Haddock(Mayo Clinic in Arizona), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Zhongxing Liao(Thoracic Surgery Foundation), Grant M. Spears(Mayo Clinic in Florida), Amy Liu(The University of Texas MD Anderson Cancer Center), Thomas J. Whitaker(Mayo Clinic)
Practical Radiation Oncology
January 21, 2021
10.1016/j.prro.2021.01.004
Cited by 18

Related Papers

Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Integrating genomic features for non-invasive early lung cancer detection
|Nature|2020|689
Neuropeptide S
|Neuron|2004|516
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
|Nature Cancer|2020|369